Systematic Targeting Of MicroPlastics (STOMP)

The Advanced Research Projects Agency for Health (ARPA‑H) is issuing Innovative Solutions Opening ARPA‑H‑SOL‑26‑152 for the Systematic Targeting of MicroPlastics (STOMP) program. The solicitation seeks proposals for Task Areas 1 and 2 (TA1, TA2) to develop a clinical system/assay (TA1) and related technologies (TA2) that address critical gaps in the current state‑of‑the‑art for the U.S. health‑care market. Proposals must include a detailed technical and management plan, a Gantt‑chart timeline, risk‑mitigation strategies, and a one‑page commercialization plan (required for TA1 and, later, TA3). Commercialization milestones are explicit: a formal commercial relationship (letter of interest, MOU, or term sheet) must be secured by month 24 for TA1 (and by month 48 for TA3). Cost proposals must be submitted in the prescribed Excel format, with full cost/price analysis for any sub‑awardees, competitive sourcing documentation, and justification for any sole‑source awards. Eligibility is limited to non‑government entities (universities, non‑profits, small and large businesses, HBCUs, MSIs, etc.); FFRDCs and other government entities are generally prohibited. Key dates: proposer day April 22, Q&A due May 4, solution summaries due May 6, full proposals due June 22. Awards will be made under Multiple Other Transaction Agreements.

Notice ID

1bf9e009957d4a9abc9d3c7133581176

Solicitation Number

ARPA-H-SOL-26-152

NAICS Code

541714

Classification Code

AN13